Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 114,780 shares at $31.48 ($3.6M) on 2018-07-02, disclosed to the SEC on 2018-07-05.
Open-market sale of $3.6M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.48 | 57,390 | $1.8M | 50.0% |
| 2 | $31.48 | 57,390 | $1.8M | 50.0% |
| Total | $31.48 avg | 114,780 | $3.6M | 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |